Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

15.8%

3 terminated/withdrawn out of 19 trials

Success Rate

78.6%

-7.9% vs industry average

Late-Stage Pipeline

16%

3 trials in Phase 3/4

Results Transparency

27%

3 of 11 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

8(57.1%)

Phase 2

3(21.4%)

Phase 4

3(21.4%)

14Total

N/A(8)

Phase 2(3)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT06832631Recruiting

VITUS Post-Market Registry

Role: lead

NCT06621524Active Not Recruiting

EucaLimus Post-Market Registry

Role: lead

NCT06678490Active Not Recruiting

Support C Post-Market Registry

Role: lead

NCT06358508Not ApplicableCompleted

Sapphire 3 CTO Study

Role: lead

NCT05929313Not ApplicableCompleted

Scoreflex TRIO - Scoring PTCA Catheter

Role: lead

NCT03216733Not ApplicableActive Not Recruiting

SORT OUT X - Combo Stent Versus ORSIRO Stent

Role: collaborator

NCT03952273Not ApplicableActive Not Recruiting

Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent

Role: collaborator

NCT02073565Not ApplicableCompleted

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

Role: lead

NCT02542007Not ApplicableCompleted

Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

Role: lead

NCT03763747Not ApplicableCompleted

Scoreflex NC - Scoring PTCA Catheter

Role: lead

NCT03052530Not ApplicableCompleted

Sapphire II PRO US Clinical Study

Role: lead

NCT02102997Terminated

Deutsches Dual Therapy Stent Register

Role: lead

NCT02183454Completed

MASCOT - Post Marketing Registry

Role: lead

NCT02723981Phase 4Withdrawn

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials

Role: collaborator

NCT00967902Phase 2Completed

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

Role: lead

NCT00732953Phase 2Completed

Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries

Role: collaborator

NCT00349895Phase 4Completed

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth

Role: lead

NCT01405287Phase 2Completed

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT

Role: lead

NCT01394848Phase 4Terminated

Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy

Role: collaborator

All 19 trials loaded